Embecta (FRA:JX7) Current Accrued Expense : €154 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Current Accrued Expense?

Embecta's Current Accrued Expense for the quarter that ended in Mar. 2025 was €154 Mil.

Embecta's quarterly Current Accrued Expense declined from Sep. 2024 (€181 Mil) to Dec. 2024 (€162 Mil) and declined from Dec. 2024 (€162 Mil) to Mar. 2025 (€154 Mil).

Embecta's annual Current Accrued Expense increased from Sep. 2022 (€154 Mil) to Sep. 2023 (€169 Mil) and increased from Sep. 2023 (€169 Mil) to Sep. 2024 (€181 Mil).

Embecta Current Accrued Expense Historical Data

The historical data trend for Embecta's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Current Accrued Expense Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Current Accrued Expense

Get a 7-Day Free Trial

73.86

93.33

154.33

168.85

181.01

Embecta Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial														163.94	184.31	181.01	162.06	154.38

Embecta Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Embecta Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Embecta's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines